跳至主要内容
临床试验/CTRI/2016/11/007460
CTRI/2016/11/007460已完成4 期

A prospective, observational study to evaluate effectiveness and safety of fixed dose combination of Indacaterol maleate 110 mcg and Glycopyrronium bromide 50 mcg in stable Chronic Obstructive Pulmonary Disease (COPD) patients - Ultibro Study

ovartis Healthcare private limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. COPD patients prescribed with FDC of Indacaterol maleate 110 mcg + Glycopyrronium bromide 50 mcg as per discretion of treating physician and as per product prescribing information.
  • 2. Patients willing to participate in the study by providing written informed consent.

排除标准

  • 1. Contraindication as per PI
  • 2. Patients simultaneously participating in other studies or use of other investigational drug at the time of enrollment or 5 times the half life of the investigational product prior to visit 1.
  • Pregnant women should not be included except if, in the opinion of the investigator, the expected benefit outweighs the potential risk to the fetus (please see Section 11 for further information).

研究者

发起方
ovartis Healthcare private limited

相似试验